ea0036P84 | (1) | BSPED2014
Alston Aileen
, Dougherty Harry
, Hayter Joanne
, Finnemore Anna
Introduction: Neonatal Graves disease is rare, affecting one in 25 000 neonates, and results from transplacental passage of TSH receptor antibodies (TSHR-Ab). Whilst hyperthyroidism occurs in <5% of babies born to mothers with active Graves disease; those born to mothers who were previously treated may still be affected. Neonatal Graves disease is usually self-limiting, however, complications include craniosynostosis, growth retardation, hyperactivity, de...